{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:12:50Z","timestamp":1779289970002,"version":"3.51.4"},"publisher-location":"Chichester, UK","reference-count":25,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004524.pub3","type":"reference-entry","created":{"date-parts":[[2006,10,20]],"date-time":"2006-10-20T00:02:14Z","timestamp":1161302534000},"source":"Crossref","is-referenced-by-count":31,"title":["Methotrexate for ankylosing spondylitis"],"prefix":"10.1002","author":[{"given":"Junmin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD004524.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/030097401753180318","article-title":"Clinical investigation of methotrexate in the treatment of ankylosing spondylitis","volume":"30","author":"Altan","year":"2001","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD004524.pub3-BIB2|cit2","first-page":"1568","article-title":"Efficacy of methotrexate in ankylosing spondylitis: A randomized, double blind, placebo controlled trial","volume":"31","author":"Gonzalez-Lopez","year":"2004","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/rheumatology\/41.11.1330","article-title":"Is methotrexate effective in ankylosing spondylitis?","volume":"41","author":"Roychowdhury","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"supplement 1","key":"10.1002\/14651858.CD004524.pub3-BIB4|cit4","first-page":"43","article-title":"Methotrexate in severe ankylosing spondylitis: A randomised placebo controlled , double-blind observer study","volume":"40","author":"Roychowdhury","year":"2001","journal-title":"Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD004524.pub3-BIB5|cit5","first-page":"460","article-title":"Methotrexate in conjunction with meloxicam for treating ankylosing spondylitis: a clinical observation of the efficacy and safety","volume":"23","author":"Xie","year":"2003","journal-title":"Academic journal of the First Medical College of PLA"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub3-BIB6|cit6","first-page":"56","article-title":"Prospective, nonblind trial of methotrexate on seronegative spondyloarthropathy","volume":"14","author":"Haque","year":"1999","journal-title":"Journal of Institute of Postgraduate Medicine & Research"},{"key":"10.1002\/14651858.CD004524.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis","volume":"46","year":"2002","journal-title":"Arthritis & Rheumatism"},{"issue":"8","key":"10.1002\/14651858.CD004524.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD004524.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s100670050027","article-title":"Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study","volume":"19","author":"Biasi","year":"2000","journal-title":"Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNFa treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Annal of Rheumatic Disseases"},{"key":"10.1002\/14651858.CD004524.pub3-BIB11|cit11","unstructured":"Cates C Visual Rx NNT Calculator 2004"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD004524.pub3-BIB12|cit12","first-page":"45","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"37","author":"Clavaguera","year":"1998","journal-title":"British Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD004524.pub3-BIB13|cit13","first-page":"1104","article-title":"Methotrexate in severe ankylosing spondylitis: an open study","volume":"22","author":"Creemers","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0950-3579(98)80046-0","article-title":"Spondyloarthropathy treatment: progress in medical therapy","volume":"12","author":"Dougados","year":"1998","journal-title":"Bailliere's clinical rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/anr.1780320221","article-title":"Favourable results using methotrexate in the treatment of patients with ankylosing spondylitis","volume":"32","author":"Handler","year":"1989","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD004524.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"supplement 59","key":"10.1002\/14651858.CD004524.pub3-BIB17|cit17","first-page":"57","article-title":"Efficacy and side effects of low dose methotrexate treatment in the patients with ankylosing spondylitis","volume":"27","author":"Kirnap","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/berh.2002.0263","article-title":"Seronegative spondyloarthritides","volume":"16","author":"Olivieri","year":"2002","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00124743-199806000-00007","article-title":"Methotrexate lacks efficacy in the treatment of severe ankylosing spondylitis compared with rheumatoid and psoriatic arthritis","volume":"4","author":"Ostendorf","year":"1998","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/030097400750002021","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"29","author":"Sampaio-Barros","year":"2000","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub3-BIB21|cit21","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004524.pub3-BIB22|cit22","first-page":"xiii","volume-title":"Evidence-based Rheumatology","author":"Tugwell","year":"2004"},{"key":"10.1002\/14651858.CD004524.pub3-BIB23|cit23","first-page":"495","article-title":"Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV","volume":"26","author":"Heijde","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"iii24","DOI":"10.1136\/ard.61.suppl_3.iii24","article-title":"Treatment trials in ankylosing spondylitis: current and future considerations","volume":"61(Suppl III)","author":"Heijde","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004524.pub3-BIB25|cit25","article-title":"Methotrexate for ankylosing spondylitis","author":"Chen","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004524.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004524.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:36:27Z","timestamp":1628530587000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004524.pub3"}},"subtitle":[],"editor":[{"given":"Junmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004524.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004524.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,10,18]]}}}